Frailty and sarcopenia in aging: diagnosis, clinical impacts, and therapeutic approaches
IOSR Journal of Humanities and Social Science · 2026-06 · 31 (6) · 25-29
DOI: 10.9790/0837-3106052529 ↗Kurz gefasst
Fachartikel in der Zeitschrift IOSR Journal of Humanities and Social Science, 2026-06. Verfasst von Daiany caixeta campos und 3 weiteren Autor:innen.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Frailty and sarcopenia were understood as interrelated geriatric syndromes, characterized by a progressive reduction in physiological reserve and the loss of muscle mass and function, which compromised autonomy and increased vulnerability to adverse events. It was observed that population aging intensified the clinical relevance of these conditions, since both were associated with falls, hospitalizations, functional disability, and increased mortality.
Objective
To analyze diagnostic methods, the main clinical impacts, and therapeutic approaches related to frailty and sarcopenia in aging, based on recent scientific evidence. Methodology: The methodology followed the PRISMA checklist recommendations, with a search conducted in the PubMed, Scielo, and Web of Science databases, considering articles published in the last 10 years. Five descriptors were used: “sarcopenia”, “frailty”, “aging”, “muscle strength”, and “elderly”. As inclusion criteria, clinical studies and reviews in humans, available in full text and published in English, Portuguese, or Spanish, were selected. Studies involving non-elderly populations, duplicate articles, and those with low methodological quality or without direct focus on the theme were excluded.
Results
The results indicated that diagnosis was based on criteria such as muscle strength, physical performance, and body composition, highlighting tools such as SARC-F and gait speed tests. It was evidenced that frailty and sarcopenia significantly increased the risk of falls, hospitalizations, and functional dependence. Interventions such as resistance exercise, protein supplementation, and vitamin D demonstrated consistent benefits.
Conclusion
It was concluded that frailty and sarcopenia represented important challenges in aging, requiring early diagnosis and multidimensional interventions. Integrated therapeutic strategies proved effective in improving functionality and quality of life.
Zitieren
APA
campos, D. C., Melo, I. P. D., Rocha, R. D. R. R., & Bessa, G. (2026). Frailty and sarcopenia in aging: diagnosis, clinical impacts, and therapeutic approaches. IOSR Journal of Humanities and Social Science, 31(6), 25-29. https://doi.org/10.9790/0837-3106052529
Vancouver
campos DC, Melo IPD, Rocha RDRR, Bessa G. Frailty and sarcopenia in aging: diagnosis, clinical impacts, and therapeutic approaches. IOSR Journal of Humanities and Social Science. 2026;31(6):25-29. doi:10.9790/0837-3106052529
BibTeX
@article{campos2026,
author = {campos, Daiany caixeta and Melo, Isabella Perilo de and Rocha, Raisa D’ Ricolli Rebouças and Bessa, Grasiela},
title = {Frailty and sarcopenia in aging: diagnosis, clinical impacts, and therapeutic approaches},
journal = {IOSR Journal of Humanities and Social Science},
year = {2026},
volume = {31},
number = {6},
pages = {25--29},
doi = {10.9790/0837-3106052529}
}
EUVIMED